TREAT TB Events
Wednesday, October 30, 2019 – Saturday, November 2, 2019
Event
Date and Time
Location
Presentation
Experience using tablet technology for detection and monitoring of hearing loss among patients with MDR-TB in the STREAM clinical trial – Ishmael Qawiy
Thursday, 12:45 – 13:45
Hall 3
Evaluation of dissemination of preliminary results from STREAM stage 1 – Samantha Kozikott
Thursday, 12:45 – 13:45
Hall 3
Community engagement in research and development: STREAM experience in building CAB networks – Oxana Rucsineanu
Thursday, 12:45 – 13:45
Hall 3
Examining the efficacy of the short MDR-TB regimen: alternative analyses from the STREAM trial – Patrick Phillips
Thursday, 16:00-17:30
MR G.05 & G.06
Health workers perception of the shorter regimen in MDR-TB treatment: qualitative evidence from Ethiopia – Laura Rosu
Friday, 10:30 – 12:00
Hall 2
Efficacy of genotype MTBDRsl assay to exclude fluoroquinolone and second-line injectable drug resistant Mycobacterium tuberculosis in a multidrug-resistant tuberculosis clinical trial – Gabriela Torrea
Friday, 10:30 – 12:00
MR 1.03 &1.04
Predictive factors of QT prolongation in STREAM 1 – Gareth Hughes
Friday, 12:45 – 13:45
Hall 3
TB medicine costs for rifampin-resistant tuberculosis treated with a shorter regimen in a clinical trial setting – Jan Komrska
Friday, 16:00 – 17:30
MR 1.05 & 1.06
Baseline predictors of unfavourable outcome in the short MDR-TB regimen: exploratory analyses from the STREAM trial – Saiam Ahmed
Saturday, 14:00 – 15:30
MR G.05 & G.06
QT prolongation and its evolution over time in STREAM 1 – Gareth Hughes
Saturday, 14:00 – 15:30
Hall 3